Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „information“
Suchtreffer
Begriffe & Kennungen
Avastin · 4.8 · Post-marketing adverse reactions are included in both Tables 1 and 2, where applicable. Detailed information a
Eintrag öffnenAvastin · 4.8 · a For further information please refer to Table 3 'Adverse reactions reported in post-marketing setting.' b Te
Eintrag öffnenAvonex · 4.8 · The safety information obtained from the use of AVONEX as an active comparator arm in a 96 week open label, ra
Eintrag öffnenAvonex · 4.8 · The safety information obtained from the use of AVONEX as an active comparator in a 96 week open label, random
Eintrag öffnenAwiqli · 4.8 · For information on daily basal insulin comparators used in each trial, please see section 5.1.
Eintrag öffnenAzacitidine Mylan · 4.8 · Elderly population There is limited safety information available with azacitidine in patients ≥ 85 years (with
Eintrag öffnenBeneFIX · 4.8 · There are insufficient data to provide information on inhibitor incidence in PUPs (see also section 5.1).
Eintrag öffnenBenlysta · 4.8 · For information on infections observed in paediatric patients with SLE see Paediatric population section below
Eintrag öffnenBenlysta · 4.8 · For information on infections observed in paediatric patients with SLE see Paediatric population section below
Eintrag öffnenBenlysta · 4.8 · For information on infections observed in paediatric patients with SLE see Paediatric population section below
Eintrag öffnenBeromun · 4.5 · The Summary of Product Characteristics for melphalan should be consulted for information on the interactions o
Eintrag öffnenBioresonanztherapie
Eintrag öffnenBridion · 4.5 · The information in this section is based on binding affinity between sugammadex and other medicinal products,
Eintrag öffnenBridion · 4.8 · 9 Additional information on special populations
Eintrag öffnenBridion · 4.8 · Information on healthy volunteers: A randomised, double-blind study examined the incidence of drug hypersensit
Eintrag öffnenBusulfan Fresenius Kabi · 4.8 · Busulfan in combination with cyclophosphamide or melphalan In adults Adverse reactions information is derived
Eintrag öffnenBusulfan Fresenius Kabi · 4.8 · Paediatric population Adverse reactions information are derived from the clinical study in paediatrics (n=55).
Eintrag öffnenCatiolanze · 4.8 · No information is provided.
Eintrag öffnenCellCept · 4.5 · 7 enterohepatic recirculation, thus leading to reduced systemic MPA exposure. Information concerning the follo
Eintrag öffnenCholib · 4.5 · Consult the prescribing information of all concomitantly used drugs to obtain further information about their
Eintrag öffnen